The weekly litigation news digest is live. Subscribe now

Formulations Of Enzalutamide

Patent No. EP3725778 (titled "Formulations Of Enzalutamide") was filed by Astellas Pharma on Sep 11, 2013. The application was issued on Aug 18, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (11)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3725778

ASTELLAS PHARMA
Application Number
EP20177837A
Filing Date
Sep 11, 2013
Status
Granted And Under Opposition
Jul 16, 2021
Publication Date
Aug 18, 2021